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Abstract
Frataxin, a nuclear encoded protein targeted to the mitochondrial matrix, has recently been
implicated as an iron chaperone that delivers ferrous iron to the iron-sulfur assembly
enzyme IscU.

During transport across the mitochondrial membrane, the N-terminal

mitochondrial targeting sequence of frataxin is cleaved in a two-step process to produce the
mature protein found in the matrix, however N-terminal extended forms of the protein have
also been observed in vivo. The recent structural characterization studies of the human
frataxin ortholog were performed on a truncated variant of the protein. Here we report the
NMR spectral assignment of an extended form of the mature human frataxin ortholog as
the basis for understanding the role of the N-terminal domain in protein function.
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Biological Context
Frataxin, a highly conserved protein found in prokaryotes and eukaryotes, is essential for cellular
iron homeostasis (Babcock, 1997). Protein deficiency in humans is the cause of the cardio- and
neurodegenerative disorder Friedreich’s ataxia (FRDA), which affects 1 in 50,000 (Delatycki, 2000).
Although expressed ubiquitously in humans, tissues with high metabolic rates like those in cardiomuscle, nerve, kidney and liver are most affected by frataxin deficiency (Campuzano, 1996). At a
cellular level, the effects of frataxin deficiency include an increase mitochondrial iron levels and a
decrease in activity of iron-sulfur (ISC)-containing proteins (Babcock, 1997; Rotig, 1997; Pandolfo,
2002). Accumulating evidence suggests frataxin participates directly in Fe-S cluster bioassembly,
either by serving as an iron chaperone that delivers Fe(II) to the cluster assembly enzyme IscU
(Yoon, 2003; Kondapalli, 2008). An alternative hypothesis, with frataxin serving as a regulatory
protein that controls assembly by interacting with partners within the pathway, has also been
reported (Adinolfi, 2009).

Frataxin’s globular domain structure is conserved between prokaryotes

and eukaryotes (see review (Bencze, 2006)) suggesting a conserved function.
In eukaryotes, frataxin maturation occurs following a two-step proteolytic processing of the
protein’s N-terminus (Condo, 2007). Processing of human frataxin’s N-terminus involves cleaving
residues 1-41 in the initial step and residues 42-80 in the final step (Condo, 2007; Schmucker, 2008).
Additional extended variants of the “mature” (residues 81-210) human frataxin have also been
found in vivo when maturation is impaired, including example constructs that span residues 56-210
and 78-210 (Schmucker, 2008). The structure of human frataxin has been solved, both by NMR and
X-ray crystallography, however complications from proteolysis and degradation of the protein’s Nterminus hindered the characterization beyond residues 88-210 (Musco, 1999; Dhe-Paganon, 2000;
Musco, 2000). Preliminary biochemical data suggests the region N-terminal to residue 88 in human
frataxin may be important in regulating the interaction between the protein and its partner IscU
(Yoon, 2007). A section of the N-terminal region in mature yeast frataxin is structured, suggesting
this region that is extended beyond the globular domain of the protein may play a functional role
(He, 2004). In order to provide a structural basis for understanding the significance of the Nterminal region in full-length human frataxin, and the N-terminal extension section in processing
variants, towards iron and protein partner binding, we characterized a stable extended full-length
human frataxin construct spanning residues 45-210 by NMR spectroscopy and obtained nearly
complete resonance assignments of these residues. These assignments set the basis for solving the
complete solution structure of full-length human frataxin and for mapping intermolecular
interactions between full-length human frataxin and binding partners.
3
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Figure 1.

15N-HSQC

spectrum of human frataxin (residues 45-210) in NMR buffer. Data were collected at a

temperature of 300° K on a 600 MHz Varian INOVA with a cold probe. Dashed red lines indicate weak peaks
(amide resonance for residues 61, 82 and 89) just below the threshold level of the plot. NH2 side chain
resonances are connected by black dashed lines.

Preliminary data suggest a high structural similarity between our 45-210 construct and the
truncated forms of the proteins that have been solved previously by NMR (Musco, 2000). Dispersion
of amide resonances in the

15N

HSQC spectra of labeled human frataxin (Figure 1) indicates the

protein is well folded. Overlays of

15N

HSQC spectra for truncated human frataxin (residues 91-

210) (Musco, 1999) and our N-terminally extended construct indicate the general structure of the
previously characterized globular domain of the protein is maintained.

A subset of amide

resonances in the additional N-terminal region of our 45-210 construct are well dispersed,
suggesting a possible partial fold for this N-terminal domain beyond the globular domain of the
protein. Analysis of chemical shift values for these N-terminal residues (45-90) following chemical
shift indices (CSI) protocols (Wishart, 1991) suggests that while a subset of residues in this region
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(residues 54, 58, 60, 62, 66, 69 and 70) show real propensity for helix formation based on HN, N, Hα,
Cα and Cβ chemical shifts, there is no real pattern to suggest a fully formed secondary structural
unit in this region (data not shown). Based on CSI analysis, residues in the region between 81-90
have chemical shifts consistent with this region being unfolded.

Methods and Experiments
Labeling, Expression and Purification of Human Frataxin - 15N-labeled and 13C/15N doubly labeled
human frataxin spanning amino acids 45 to 210 were obtained from bacteria grown in M9 minimal
medium with

15NH

4Cl

and U-13C6 D-glucose as the sole nitrogen and carbon sources respectively.

The construct contained an N-terminal poly-His tag which was included for purification purposes
and not removed (Yoon, 2007). The constructs were expressed in E. coli BL21 (DE3) strain
transformed with a modified pET 28b(+) vector DNA.

For protein expression, the cells were

inoculated into 4 liters of M9 medium with kanamycin (50 mg/L) induced for 16 hours by addition of
0.3 mM IPTG after the cultures reached an optical density between 0.4 – 0.6 at 600 nm.
Cell pellets were resuspended in buffer A (50 mM sodium phosphate, 300 mM NaCl, 10% glycerol,
pH 7.0) supplemented with 1 mM TCEP, 0.1% Triton X-100, 75 ng/mL lysozyme, DNase I. Cell lysis
was achieved by sonication (10 s pulse / 2 min) for 30 min at 4°C. Lysate was centrifuged at 15,000
rpm for 30 min at 4°C. The supernatant was loaded onto a TALON resin preequilibrated with buffer
A. Subsequently, the loaded resin was washed with 10 bed volumes of buffer A, 5 bed volumes of
buffer A with 5 mM imidazole and 5 bed volumes of buffer A with 10 mM imidazole. Protein was
eluted with buffer A and 200 mM imidazole, pH 7.0. Protein purity was assessed by SDS-PAGE.
For NMR experiments, buffer was exchanged by dialysis against 100 mM sodium phosphate, pH 7.5.
Concentration was determined by absorbance at 280 nm (ε280 = 33920 M-1 cm-1).

Nuclear Magnetic Resonance Spectroscopy (NMR) - Frataxin samples used in the structure
determination were prepared at 1 mM concentration in NMR buffer (100 mM sodium phosphate, pH
7.5, 90% H2O and 10% D2O). NMR spectra were acquired at 300 K on an Varian INOVA 600 MHz
spectrometer equipped with a triple resonance 1H/13C/15N Varian cold probe with z-axis pulsed field
gradients. Sequence specific backbone assignments were done using the following experiments: 15NHSQC, HNCACB, CBCA(CO)NH and HNCO (Cavanagh 1996). Side chain atom assignments were
made

using

1H-13CHSQC,

H(CCO)NH-TOCSY,

C(CO)NHTOCSY

and

15N-filtered

TOCSY

experiments. All spectra were analyzed according to established lab protocols (He, Alam et al. 2004)
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using the processing programs NMRPipe (Delaglio, Grzesiek et al. 1995) and Sparky (Goddard and
Kneller 2001).

Assignments and Data Deposition
Residue assignments for the full-length human frataxin protein are provided in the high-resolution
15N-HSQC

spectrum for the protein (Figure 1). Full backbone and side chain assignments was

achieved for 160 out of 167 possible residues. For further reference, the residue sequence for fulllength human frataxin can be found at http://www.uniprot.org/uniprot/Q16595.

Chemical shift

assignments are deposited in the Biological Magnetic Resonance Bank (http://www.bmrb.wisc.edu/)
under the accession code BMRB-15736.
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